Chronic Myelomonocytic Leukemia: Diagnosis and Treatment

Written by Medicover Team and Medically Reviewed by Dr Nilesh Wasekar , Hematologists

Causes
Find a Doctor
Diagnosis
Treatment
FAQs
Book an Appointment

1. Causes 2. Find a Doctor 3. Diagnosis 4. Treatment 5. FAQs

Chronic Myelomonocytic Leukemia (CMML) is a rare type of blood cancer that affects the bone marrow and blood-forming cells. It is characterized by an increased number of monocytes, a type of white blood cell, in the bloodstream and bone marrow. CMML has features of both myelodysplastic syndromes and myeloproliferative neoplasms, leading to abnormal blood cell production and function.

Common symptoms include fatigue, frequent infections, easy bruising or bleeding, weight loss, and an enlarged spleen. Early diagnosis and appropriate treatment can help manage symptoms, slow disease progression, and improve quality of life.

What are the Types of Chronic Myelomonocytic Leukemia?

CMML is classified into two types based on the number of immature white blood cells (blasts) in the blood and bone marrow:

CMML-1: Less than 5% blasts in the blood and less than 10% in the bone marrow.
CMML-2: 5-19% blasts in the blood or 10-19% blasts in the bone marrow.

What are the Symptoms of Chronic Myelomonocytic Leukemia?

The symptoms of CMML can vary and often overlap with those of other conditions, making diagnosis challenging. Common symptoms include:

Fatigue: Due to anemia caused by a low red blood cell count.
Fever and Night Sweats: Common systemic symptoms associated with blood cancers.
Weight Loss: Unintentional weight loss without an obvious cause.
Splenomegaly: Enlargement of the spleen causing pain or fullness in the upper abdomen.
Infections: Increased susceptibility due to abnormal white blood cell function.
Bruising or Bleeding: Easy bruising or prolonged bleeding caused by low platelet counts.

What are the Causes of Chronic Myelomonocytic Leukemia?

The exact cause of CMML is unknown, but several genetic and environmental factors are associated with an increased risk of developing the disease.

Genetic Mutations

Mutations in genes such as TET2, SRSF2, and ASXL1 are commonly found in people with CMML. These mutations interfere with normal blood cell development and promote abnormal cell growth.

Environmental Factors

Exposure to chemicals such as benzene and previous chemotherapy or radiation therapy for other cancers may increase the risk of developing CMML.

Age and Gender

CMML is more common in older adults, with the average age at diagnosis around 70 years, and it occurs more frequently in men than women.

When to See a Doctor for Chronic Myelomonocytic Leukemia?

If you experience persistent fatigue, unexplained weight loss, frequent infections, or abnormal bleeding, consult a Hematologist promptly. Early diagnosis and treatment can help manage the disease, reduce complications, and improve long-term outcomes and quality of life.

If you experience persistent fatigue, weakness, or shortness of breath that does not improve with rest.
If you develop frequent infections, fever, or recurrent illnesses due to low immunity.
If you notice easy bruising, prolonged bleeding, nosebleeds, or bleeding gums.
If you have unexplained weight loss, loss of appetite, or excessive night sweats.
If you experience pain or fullness in the upper left side of the abdomen caused by an enlarged spleen.
If routine blood tests reveal abnormal blood cell counts or increased monocyte levels.
If you develop severe bleeding, chest pain, difficulty breathing, or sudden neurological symptoms, seek emergency medical care immediately.
If your symptoms persist or worsen, consult a Hematologist promptly for a comprehensive evaluation, appropriate investigations, diagnosis, and a personalized treatment plan.

Find Hematologists for Chronic Myelomonocytic Leukemia Treatment Near You

Doctor for Chronic Myelomonocytic Leukemia in Vizag

Doctor for Chronic Myelomonocytic Leukemia in Nashik

How is Chronic Myelomonocytic Leukemia Diagnosed?

Diagnosing CMML requires a combination of clinical assessment, laboratory investigations, bone marrow examination, and genetic testing.

Blood Tests

Complete Blood Count (CBC): Measures different blood cell types and often shows increased monocytes and abnormal blood counts.
Peripheral Blood Smear: Examines the appearance of blood cells under a microscope.

Bone Marrow Biopsy

A bone marrow biopsy helps identify abnormal blood-forming cells and distinguishes CMML from other blood disorders.

Genetic Testing

Molecular testing identifies specific genetic mutations that help confirm the diagnosis and guide treatment decisions.

How is Chronic Myelomonocytic Leukemia Treated?

Treatment depends on the patient's age, overall health, symptoms, and disease severity. The primary goals are to control symptoms, slow disease progression, and improve quality of life.

Supportive Care

Supportive treatments help relieve symptoms and prevent complications.

Blood Transfusions: Red blood cell or platelet transfusions to manage anemia and bleeding.
Antibiotics: Used to prevent or treat infections.

Drug Therapy

Hypomethylating Agents: Drugs such as azacitidine and decitabine reduce abnormal bone marrow cell growth.
Chemotherapy: Traditional chemotherapy may be recommended in selected cases.

Targeted Therapy

Targeted medications are designed to block abnormal genetic pathways involved in CMML and may improve treatment outcomes with fewer side effects.

Stem Cell Transplantation

Allogeneic stem cell transplantation offers the only potential cure for eligible patients but is generally reserved for younger and healthier individuals due to its associated risks.

Your health is everything - prioritize your well-being today.

Consult Chronic Myelomonocytic Leukemia Doctors Today

How is Chronic Myelomonocytic Leukemia Prevented and What is the Prognosis?

There is no proven way to prevent CMML because its exact cause remains unknown. However, minimizing exposure to harmful chemicals and maintaining overall health may help reduce risk.

Prognosis

The outlook for CMML varies depending on disease characteristics and the patient's overall health.

Blast Count: Higher blast counts are associated with a poorer prognosis.
Genetic Mutations: Certain mutations indicate a more aggressive disease.
Patient's Age and Overall Health: Younger and healthier patients generally have better outcomes.

How is Living With Chronic Myelomonocytic Leukemia?

Living with CMML requires regular medical follow-up, healthy lifestyle choices, and emotional support to effectively manage the disease and maintain quality of life.